Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors.
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors / Falanga A, Marchetti M, Massi D, Merelli B, Verzeroli C, Russo L, Rulli E, Tondini C, Legramandi L, Nassini R, Scatena C, De Logu F, Cattaneo L, Mandalà M.. - In: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. - ISSN 0190-9622. - ELETTRONICO. - 74(6)::(2016), pp. 1254-1256. [10.1016/j.jaad.2015.11.006]
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors.
Massi D;RUSSO, LORENZO;Nassini R;De Logu F;
2016
Abstract
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Falanga_letter.pdf
Open Access dal 01/01/2018
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
1.53 MB
Formato
Adobe PDF
|
1.53 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
